# Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain

> **NCT05775510** · — · TERMINATED · sponsor: **MedtronicNeuro** · enrollment: 91 (actual)

## Conditions studied

- Pain, Intractable
- Pain, Chronic

## Interventions

- **DEVICE:** Commercially available neurostimulation systems

## Key facts

- **NCT ID:** NCT05775510
- **Lead sponsor:** MedtronicNeuro
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2023-04-25
- **Primary completion:** 2025-05-29
- **Final completion:** 2025-05-29
- **Target enrollment:** 91 (ACTUAL)
- **Why stopped:** Medtronic refocused on the most impactful global evidence needs for SCS. The decision wasn't related to safety or quality. Pilot data was sufficient, but the study ended early and did not move into the Data at Scale phase.
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05775510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05775510, "Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05775510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*